|
Cancer Center Support Grant
|
5P30CA015704-43
|
$9,559,285
|
$95,593
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
SPORE in Multple Myeloma
|
5P50CA100707-13
|
$2,185,000
|
|
ANDERSON, KENNETH
|
DANA-FARBER CANCER INST
|
|
SPORE in Prostate Cancer
|
1P50CA180995-01A1
|
$2,185,000
|
|
CATALONA, WILLIAM
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
SPORE in Lung Cancer
|
5P50CA058187-20
|
$2,185,000
|
|
BUNN, PAUL
|
UNIVERSITY OF COLORADO DENVER
|
|
Oncohistones: Role of Histone H3 Mutations in the Oncogenesis of Pediatric Cancer
|
1P01CA196539-01
|
$2,023,721
|
|
ALLIS, CHARLES
|
ROCKEFELLER UNIVERSITY
|
|
Biology and Transplantation of the Hematopoietic Stem Cell
|
2P01CA065493-21
|
$1,940,892
|
|
WAGNER, JOHN
|
UNIVERSITY OF MINNESOTA
|
|
Retrovirus Models of Cancer
|
5P01CA100730-12
|
$1,785,690
|
|
GREEN, PATRICK
|
OHIO STATE UNIVERSITY
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,537,925
|
$61,517
|
Barr, Frederic
|
CCR (NCI)
|
|
The Partnership for Native American Cancer Prevention (2 of 2)
|
5U54CA143924-07
|
$1,375,226
|
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
Endoplasmic Reticulum Chaperones in Cancer Biology and Therapy
|
1P01CA186866-01A1
|
$1,337,450
|
|
LI, ZIHAI
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Vascular Biology Section
|
ZIA BC 011390
|
$1,186,781
|
$296,695
|
Lin, Pengnian Charles
|
CCR (NCI)
|
|
Stromal Regulation of Bone Metastasis
|
5U54CA163191-06
|
$1,129,443
|
|
KALLURI, RAGHU
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Cellular Interactions with Thrombospondin
|
ZIA SC 009172
|
$1,003,208
|
$50,160
|
Roberts, David
|
CCR (NCI)
|
|
Signal Transduction of Paired Inhibitory Receptors of NK Cells and Macrophages
|
ZIA BC 010300
|
$965,550
|
$96,555
|
McVicar, Daniel
|
CCR (NCI)
|
|
The Women's Health Study: Infrastructure Support for Continued Cohort Follow-up
|
5UM1CA182913-02
|
$885,018
|
|
BURING, JULIE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Imaging and Molecular Correlates of Progression in Cystic Neoplasms of the Pancre
|
1U01CA196403-01
|
$860,394
|
|
MAITRA, ANIRBAN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Multidiciplinary Integrative Genomic Approach to Distinguish Lethal from Indolent
|
1U01CA196390-01
|
$809,998
|
|
SCHAEFFER, EDWARD
|
JOHNS HOPKINS UNIVERSITY
|
|
Stanford Molecular and Cellular Characterization Laboratory
|
1U01CA196387-01
|
$799,493
|
|
BROOKS, JAMES
|
STANFORD UNIVERSITY
|
|
Biologic Determinants of the Natural History of AIDS-Defining Cancers in Uganda
|
5U54CA190146-02
|
$780,706
|
|
CASPER, COREY
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Schiff base forming sunscreen filters for long-wear UV protection
|
5R44CA171419-03
|
$750,000
|
|
ISAACMAN, STEVEN
|
NANOMETICS, LLC
|
|
A new small molecule targeting agent and therapeutic for non-Hodgkin's lymphoma
|
5R44CA159843-03
|
$740,587
|
|
BALHORN, RODNEY
|
SHAL TECHNOLOGIES, INC.
|
|
PSA Peptidase Activity (PPA): A New Biomarker for Prostate Cancer Aggressiveness
|
5R44CA156786-03
|
$738,935
|
|
LAI, FANG
|
OHMX CORPORATION
|
|
Improving treatment of cardiovascular risk factors in childhood cancer survivors
|
5R01CA204378-02
|
$734,545
|
$734,545
|
CHOW, ERIC
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
HIV and Hepatocellular Carcinoma in Uganda: The H2U Consortium
|
5U54CA190165-02
|
$699,900
|
|
KIRK, GREGORY
|
JOHNS HOPKINS UNIVERSITY
|
|
(PQC4) Habitats in Prostate Cancer
|
5R01CA190105-02
|
$692,000
|
|
GILLIES, ROBERT
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Uganda-UCSF Consortium on Prevention and Early Detection of HIV-Associated Cancer
|
5U54CA190153-02
|
$680,259
|
|
MARTIN, JEFFREY
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Understanding and Targeting Chemotherapy Resistance in Acute Myeloid Leukemia
|
1R01CA198089-01
|
$679,353
|
|
CARROLL, MARTIN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Diffusion Weighted Breast MR Imaging for Screening Women with Dense Breasts
|
5R44CA186313-03
|
$676,958
|
|
PENN, ALAN
|
ALAN PENN AND ASSOCIATES, INC.
|
|
A Post-Visit Patient Portal Tool to Promote Colorectal Cancer Screening
|
1R01CA197205-01
|
$644,672
|
|
ELSTON LAFATA, JENNIFER
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Accurate MR-based PET Attenuation Correction for Quantitative Clinical Trials
|
1R01CA196687-01
|
$620,305
|
|
MUZIC, RAYMOND
|
CASE WESTERN RESERVE UNIVERSITY
|
|
PQB-3: Discovery and validation of the driving mediators of cancer cachexia
|
5R01CA190101-02
|
$615,301
|
|
GOLUB, TODD
|
BROAD INSTITUTE, INC.
|
|
(PQC-1) Driver Events In IBD-Associated Neoplastic Progression
|
5R01CA190040-02
|
$613,138
|
|
MELTZER, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
|
Prospective Study of Human Oral Microbiome and Pancreatic Cancer Risk
|
5R01CA164964-02
|
$593,181
|
|
AHN, JIYOUNG
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
High Resolution Microendoscopy for the Management of Esophageal Neoplasia
|
5R01CA181275-02
|
$589,926
|
|
ANANDASABAPATHY, SHARMILA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Physical Activity Impacts of a Planned Activity-Friendly Community: The What, Wh
|
1R01CA197761-01
|
$579,739
|
|
ORY, MARCIA
|
TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR
|
|
High Deductible Insurance: Impact on Breast Cancer Care and Outcomes
|
5R01CA172639-03
|
$572,681
|
|
WHARAM, JAMES
|
HARVARD PILGRIM HEALTH CARE, INC.
|
|
Applicability of Mouse Breast Cancer Models to Tumor-Immune Network Investigation
|
1R01CA196657-01
|
$570,517
|
|
ENGLEMAN, EDGAR G.
|
STANFORD UNIVERSITY
|
|
Collaborative Research in Integrative Cancer Biology
|
5U01CA184902-02
|
$564,382
|
|
CLARKE, ROBERT
|
GEORGETOWN UNIVERSITY
|
|
Molecular Discriminators in Benign Breast Tissue for Future Risk of ER positive a
|
5R01CA187112-02
|
$561,339
|
|
DEGNIM, AMY
|
MAYO CLINIC ROCHESTER
|
|
Research Training in Pediatric Oncology
|
5T32CA136432-07
|
$539,654
|
|
ORKIN, STUART
|
DANA-FARBER CANCER INST
|
|
A FAP-Activated Proteasome Inhibitor for Killing Solid Tumors
|
5R42CA156930-03
|
$532,072
|
|
JONES, BARRY
|
ARISAPH PHARMACEUTICALS, INC.
|
|
Increasing Cancer Detection Yield Using Breast MRI Screening Modality
|
1R01CA197150-01
|
$521,919
|
|
ZHENG, BIN
|
UNIVERSITY OF OKLAHOMA NORMAN
|
|
Point-of-Care Diagnostic Tools to Improve Global Cervical Cancer Control Programs
|
5UH2CA189910-02
|
$500,000
|
|
SCHMELER, KATHLEEN
|
RICE UNIVERSITY
|
|
An Early-Phase Clinical Trial Evaluating ABC294640 in Patients with Refractory/Re
|
5R42CA183708-04
|
$499,411
|
|
PARSONS, CHRISTOPHER
|
APOGEE BIOTECHNOLOGY CORPORATION
|
|
Low-cost Enabling Technology for Image-guided Photodynamic Therapy (PDT) of Oral
|
5UH2CA189901-02
|
$495,304
|
|
HASAN, TAYYABA
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Performance, safety, and efficacy of a new cyrotherapy device for cervical dyspl
|
5UH2CA189923-02
|
$487,661
|
|
ANDERSON, JEAN
|
JOHNS HOPKINS UNIVERSITY
|
|
Development of a New Generation Micro-CT imaging for Functional and Molecular Ima
|
1R01CA196667-01
|
$485,737
|
|
BADEA, CRISTIAN
|
DUKE UNIVERSITY
|
|
Training in Molecular& Genetic Epidemiology of Cancer
|
5R25CA112355-11
|
$484,136
|
|
WITTE, JOHN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Functional Analysis of TEM5 and TEM8
|
ZIA BC 010484
|
$482,896
|
$241,448
|
St. Croix, Brad
|
CCR (NCI)
|
|
Effects of Physical Activity Calorie Expenditure (PACE) Food Labeling
|
5R01CA184473-02
|
$467,265
|
|
VIERA, ANTHONY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
Total relevant funding to Vascular Disease for this search: $1,782,530
|